Eight years after its inception, our comprehensive genomic study on the paratyphoid B fever agent has been published: https://t.co/25aP18wsRj
Many thanks to all coauthors and funders (La fondation Le Roch-Les #Mousquetaires,
@institutpasteur, @SantePubliqueFr, and @IbeidLabex)
đExplore the frontlines of global health with Peter Hotez!
A must-watch conference on vaccines and infectious disease challenges.
Dive into the science shaping our world đ
@institutpasteur@PeterHotez@IbeidLabex
https://t.co/0CFt1aaE4C
đ We are thrilled to expand our horizons.
The Labex IBEID is now on Bluesky!
Join us for more insights and conversations about science and emerging #infectiousDiseases
đ Find us at https://t.co/pwFh330PvC
@IbeidLabex@institutpasteur
Our amazing PhD studentârecently graduated đ presenting his works on the findings of autoantibodies against type I IFNs as major determinants of West Nile virus and tick-borne encephalitis. BRAVO @grvsadrian đ
Dear #Klebsiella community: only one month to go before #KLEBS2024 We are looking forward to hosting you in Paris @institutpasteur . **Please do not forget to complete your registration very soon**. A trĂšs bientĂŽt !
âïžA huge thank you to everyone who joined us in celebrating the 15th anniversary of our Labex IBEID.
Your participation made this event a true success. We look forward to many more years of groundbreaking research and innovation together!
#science#research#InfectiousDiseases
Philippe Bastin is now on stage for the closing of our conference!
Thank you to all for your oral and poster presentations and the high quality of scientific results we shared during the last 3 days!
#science#onehealth#infectiousdiseases#vaccine@institutpasteur
Our next selected speaker is Francisco Jose Martinez Blazquez from the Institut Pasteur presenting his work on the role of PvDBPII in antibody-mediated reduction of Plasmodium growth
#malaria#science#infectiousdiseases@institutpasteur